SUN PHARMA GLOBAL FZE
Patent Applications and Registrations
Patent applications and USPTO patent grants for SUN PHARMA GLOBAL FZE.The latest application filed is for "topical formulations and uses thereof".
- SUN PHARMA GLOBAL FZE - Sharjah AE
Trademarks
| Patent | Date |
|---|---|
| Methods for treating ocular inflammatory diseases Grant 11,154,560 - Bowman , et al. October 26, 2 | 2021-10-26 |
| Topical Formulations And Uses Thereof App 20210268114 - WEISS; Sidney L. | 2021-09-02 |
| Methods For Treating Ocular Inflammatory Diseases App 20210205330 - BOWMAN; Lyle M ; et al. | 2021-07-08 |
| Topical Cyclosporine-containing Formulations And Uses Thereof App 20210145924 - WEISS; Sidney L. ; et al. | 2021-05-20 |
| Methods for treating ocular inflammatory diseases Grant 10,980,818 - Bowman , et al. April 20, 2 | 2021-04-20 |
| Topical cyclosporine-containing formulations and uses thereof Grant 10,918,694 - Weiss , et al. February 16, 2 | 2021-02-16 |
| Methods For Treating Ocular Inflammatory Diseases App 20200183808 - BOWMAN; Lyle M. ; et al. | 2020-06-11 |
| Topical Formulations And Uses Thereof App 20200009137 - WEISS; Sidney L. | 2020-01-09 |
| Methods For Treating Ocular Inflammatory Diseases App 20190332516 - BOWMAN; Lyle M. ; et al. | 2019-10-31 |
| Topical formulations and uses thereof Grant 10,441,630 - Mitra , et al. Oc | 2019-10-15 |
| Methods For Treating Ocular Inflammatory Diseases App 20190298738 - BOWMAN; Lyle M. ; et al. | 2019-10-03 |
| Oral formulation and suspension of an oncology drug Grant 10,426,781 - Decaudin , et al. October 1, 2 | 2019-10-01 |
| Topical Formulations And Uses Thereof App 20190231885 - WEISS; Sidney L. | 2019-08-01 |
| Abiraterone steroid formulation Grant 10,292,990 - Nemeth , et al. | 2019-05-21 |
| Topical Cyclosporine-containing Formulations And Uses Thereof App 20190060397 - WEISS; Sidney L. ; et al. | 2019-02-28 |
| Methods for treating ocular inflammatory diseases Grant 10,201,548 - Bowman , et al. Feb | 2019-02-12 |
| Abiraterone Acetate Formulation and Methods of Use App 20190008874 - Murphy; Maura ; et al. | 2019-01-10 |
| Topical Formulations And Uses Thereof App 20180333352 - WEISS; Sidney L. | 2018-11-22 |
| Oral formulation and suspension of an oncology drug Grant 9,943,520 - Decaudin , et al. April 17, 2 | 2018-04-17 |
| Topical formulations and uses thereof Grant 9,937,225 - Mitra , et al. April 10, 2 | 2018-04-10 |
| Oral Formulation And Suspension Of An Oncology Drug App 20180071305 - Decaudin; Celine ; et al. | 2018-03-15 |
| Process For Preparation Of Citalopram And Enantiomers App 20110251410 - NAGARAJAN; Periyandi ; et al. | 2011-10-13 |
| Process for preparation of citalopram and enantiomers Grant 7,989,645 - Nagarajan , et al. August 2, 2 | 2011-08-02 |
| Process for preparation of citalopram and enantiomers Grant 7,964,742 - Nagarajan , et al. June 21, 2 | 2011-06-21 |
| Process For Preparation Of Citalopram And Enantiomers App 20100249437 - NAGARAJAN; Periyandi ; et al. | 2010-09-30 |
| Process for preparation of citalopram and enantiomers Grant 7,790,935 - Nagarajan , et al. September 7, 2 | 2010-09-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 